Výsledky vyhledávání - Lothar Roessig
- Zobrazuji výsledky 1 - 20 z 32
- Přejít na další stránku
-
1
-
2
Vericiguat and NT‐proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial Autor Michele Senni, J. López‐Sendón, Alain Cohen‐Solal, Piotr Ponikowski, Richard Nkulikiyinka, Cecilia Freitas, Vanja Vlajnic, Lothar Roessig, Burkert Pieske
Vydáno 2022Revisão -
3
Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction Autor Diana Bonderman, Stefano Ghio, Stephan B. Felix, Hossein Ardeschir Ghofrani, Evangelos D. Michelakis, Veselin Mitrović, Ronald J. Oudiz, Francis Boateng, Andrea‐Viviana Scalise, Lothar Roessig, Marc J. Semigran
Vydáno 2013Artigo -
4
The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction Autor Stephen J. Greene, Mihai Gheorghiade, Barry A. Borlaug, Burkert Pieske, Muthiah Vaduganathan, John C. Burnett, Lothar Roessig, Johannes‐Peter Stasch, Scott D. Solomon, Walter J. Paulus, Javed Butler
Vydáno 2013Revisão -
5
Patient Selection in Heart Failure With Preserved Ejection Fraction Clinical Trials Autor Jacob P. Kelly, Robert J. Mentz, Alexandre Mebazaa, Adriaan A Voors, Javed Butler, Lothar Roessig, Mona Fiuzat, Faı̈ez Zannad, Bertram Pitt, Christopher M. O’Connor, Carolyn S.P. Lam
Vydáno 2015Revisão -
6
Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1) Autor Diana Bonderman, Ingrid Pretsch, Regina Steringer‐Mascherbauer, Pavel Jansa, Stephan Rosenkranz, Caroline Tufaro, Andja Bojic, Carolyn S.P. Lam, Reiner Frey, Michael Ochan Kilama, Sigrun Unger, Lothar Roessig, Iréne Lang
Vydáno 2014Artigo -
7
Left atrial strain as sensitive marker of left ventricular diastolic dysfunction in heart failure Autor Athanasios Frydas, Daniel A. Morris, Evgeny Belyavskiy, Aravind‐Kumar Radhakrishnan, Martin Kropf, Marijana Tadić, Lothar Roessig, Carolyn S.P. Lam, Sanjiv J. Shah, Scott D. Solomon, Burkert Pieske, Elisabeth Pieske‐Kraigher
Vydáno 2020Artigo -
8
Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRES... Autor Burkert Pieske, Aldo P. Maggioni, Carolyn S.P. Lam, Elisabeth Pieske‐Kraigher, Gerasimos Filippatos, Javed Butler, Piotr Ponikowski, Sanjiv J. Shah, Scott D. Solomon, Andrea‐Viviana Scalise, Katharina Mueller, Lothar Roessig, Mihai Gheorghiade
Vydáno 2016Artigo -
9
Rationale and design of the <scp>SOluble</scp> guanylate Cyclase <scp>stimulatoR</scp> in <scp>heArT failurE</scp> Studies (<scp>SOCRATES</scp>) Autor Burkert Pieske, Javed Butler, Gerasimos Filippatos, Carolyn S.P. Lam, Aldo P. Maggioni, Piotr Ponikowski, Sanjiv J. Shah, Scott D. Solomon, Elisabeth Kraigher‐Krainer, Eliana T. Samano, Andrea Scalise, Katharina Müller, Lothar Roessig, Mihai Gheorghiade
Vydáno 2014Artigo -
10
Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction Autor Mihai Gheorghiade, Stephen J. Greene, Javed Butler, Gerasimos Filippatos, Carolyn S.P. Lam, Aldo P. Maggioni, Piotr Ponikowski, Sanjiv J. Shah, Scott D. Solomon, Elisabeth Kraigher‐Krainer, Eliana T. Samano, Katharina Müller, Lothar Roessig, Burkert Pieske
Vydáno 2015Artigo -
11
Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial Autor Carolyn S.P. Lam, Hillary Mulder, Yuri Lopatin, Jose Vazquez-Tanus, D. Siu, Justin A. Ezekowitz, Burkert Pieske, Christopher M. O’Connor, Lothar Roessig, Mahesh J. Patel, Kevin J. Anstrom, Adrian F. Hernandez, Paul W. Armstrong
Vydáno 2021Artigo -
12
Patient‐reported outcomes in the <scp>SOluble</scp> guanylate Cyclase <scp>stimulatoR</scp> in <scp>heArT failurE patientS</scp> with <scp>PRESERVED</scp> ejection fraction (<scp>S... Autor Gerasimos Filippatos, Aldo P. Maggioni, Carolyn S.P. Lam, Elisabeth Pieske‐Kraigher, Javed Butler, John A. Spertus, Piotr Ponikowski, Sanjiv J. Shah, Scott D. Solomon, Andrea‐Viviana Scalise, Katharina Mueller, Lothar Roessig, Luke Bamber, Mihai Gheorghiade, Burkert Pieske
Vydáno 2017Artigo -
13
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator Autor Paul W. Armstrong, Lothar Roessig, Mahesh J. Patel, Kevin J. Anstrom, Javed Butler, Adriaan A. Voors, Carolyn S.P. Lam, Piotr Ponikowski, Tracy Temple, Burkert Pieske, Justin A. Ezekowitz, Adrian F. Hernandez, Joerg Koglin, Christopher M. O’Connor
Vydáno 2017Revisão -
14
Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial Autor Burkert Pieske, Mahesh J. Patel, Cynthia M. Westerhout, Kevin J. Anstrom, Javed Butler, Justin A. Ezekowitz, Adrian F. Hernandez, Joerg Koglin, Carolyn S.P. Lam, Piotr Ponikowski, Lothar Roessig, Adriaan A. Voors, Christopher M. O’Connor, Paul W. Armstrong
Vydáno 2019Artigo -
15
Heart Failure Clinical Trials in East and Southeast Asia Autor Robert J. Mentz, Lothar Roessig, Barry Greenberg, Naoki Sato, Kaori Shinagawa, Daniel Yeo, Bernard W.K. Kwok, Eugenio Reyes, Henry Krum, Burkert Pieske, Stephen J. Greene, Andrew P. Ambrosy, Jacob P. Kelly, Faı̈ez Zannad, Bertram Pitt, Carolyn S.P. Lam
Vydáno 2016Revisão -
16
N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes Autor Justin A. Ezekowitz, Christopher M. O’Connor, Richard W. Troughton, Wendimagegn Alemayehu, Cynthia M. Westerhout, Adriaan A. Voors, Javed Butler, Carolyn S.P. Lam, Piotr Ponikowski, Michele Emdin, Mahesh J. Patel, Burkert Pieske, Lothar Roessig, Adrian F. Hernandez, Paul W. Armstrong
Vydáno 2020Artigo -
17
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction Autor Paul W. Armstrong, Burkert Pieske, Kevin J. Anstrom, Justin A. Ezekowitz, Adrian F. Hernandez, Javed Butler, Carolyn S.P. Lam, Piotr Ponikowski, Adriaan A. Voors, Gang Jia, Steven E. McNulty, Mahesh J. Patel, Lothar Roessig, Joerg Koglin, Christopher M. O’Connor
Vydáno 2020Artigo -
18
Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the <scp>VICTORIA</scp> (<scp>Vericiguat</scp> G... Autor Adriaan A. Voors, Hillary Mulder, Eugene B. Reyes, Martín Cowie, Johan Lassus, Adrian F. Hernandez, Justin A. Ezekowitz, Javed Butler, Christopher M. O’Connor, Joerg Koglin, Carolyn S.P. Lam, Burkert Pieske, Lothar Roessig, Piotr Ponikowski, Kevin J. Anstrom, Paul W. Armstrong
Vydáno 2021Artigo -
19
Vericiguat in patients with atrial fibrillation and heart failure with reduced ejection fraction: insights from the <scp>VICTORIA</scp> trial Autor Piotr Ponikowski, Wendimagegn Alemayehu, Ali̇ Oto, M. Cecilia Bahit, Ebrahim Noori, Mahesh J. Patel, Javed Butler, Justin A. Ezekowitz, Adrian F. Hernandez, Carolyn S.P. Lam, Christopher M. O’Connor, Burkert Pieske, Lothar Roessig, Adriaan A. Voors, Cynthia M. Westerhout, Paul W. Armstrong
Vydáno 2021Artigo -
20
Efficacy and safety of vericiguat in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan: insights from the VICTORIA trial Autor Michele Senni, Wendimagegn Alemayehu, David Sim, Frank Edelmann, Javed Butler, Justin A. Ezekowitz, Adrian F. Hernandez, Carolyn S.P. Lam, Christopher M. O’Connor, Burkert Pieske, Piotr Ponikowski, Lothar Roessig, Adriaan A. Voors, Cynthia M. Westerhout, Ciaran J. McMullan, Paul W. Armstrong
Vydáno 2022Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Heart failure
Cardiology
Ejection fraction
Pathology
Alternative medicine
Placebo
Clinical trial
Heart failure with preserved ejection fraction
Natriuretic peptide
Randomized controlled trial
Clinical endpoint
Computer science
Confidence interval
Hazard ratio
Intensive care medicine
Pharmacology
Randomization
Atrial fibrillation
Blood pressure
Chemistry
Environmental health
Fraction (chemistry)
Guanylate cyclase
Health care
Myocardial infarction
Nursing
Organic chemistry
Population